Carol M. Amato

Also affiliated with Azienda Ospedaliero-Universitaria Careggi

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Circulating CD8+ MAIT cells correlate with improved outcomes in anti-PD1 treated melanoma patients”.

Circulating CD8+ MAIT cells correlate with improved outcomes in anti-PD1 treated melanoma patients

medRxiv(2020)10.1101/2020.08.20.20178988

N/A

0DataRank · unranked

1 citations

Dana M. Davis, Robert J. Van Gulick, Robert J. Torphy, Jessica S.W. Borgers, Jared Klarquist +12 more

Targeting CDK4/6 Represents a Therapeutic Vulnerability in Acquired BRAF/MEK Inhibitor–Resistant Melanoma

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-20-1126

N/A

0DataRank · unranked

38 citations

Jennifer D. Hintzsche, Stacey M. Bagby, Veronica L. Espinoza, Christophe Langouët-Astrié, Carol M. Amato +6 more

Supplementary Tables and Figures from Targeting CDK4/6 Represents a Therapeutic Vulnerability in Acquired BRAF/MEK Inhibitor–Resistant Melanoma

Figshare(2023)10.1158/1535-7163.22521675.v1

N/A

0DataRank · unranked

0 citations

Jennifer D. Hintzsche, Stacey M. Bagby, Verónica Espinoza, Christophe Langouët-Astrié, Carol M. Amato +6 more

DNA-PK inhibition enhances neoantigen diversity and increases T cell responses to immunoresistant tumors

Journal of Clinical Investigation(2024)10.1172/jci180278

N/A

0DataRank · unranked

9 citations

Gabriella Albert, Amelia Sánchez, Jiangli Chen, Jianjun Liu, Andres S. Davalos +11 more